Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about BAYER AG
09:44aBAYER : Finerenone significantly reduced renal and cardiovascular outcomes in pa..
AQ
08:35aBAYER : Rivaroxaban application submitted to U.S. FDA for new indication in pati..
PU
07:45aBAYER AG : UBS keeps its Buy rating
MD
07:32aBAYER AG : Buy rating from Goldman Sachs
MD
03:45aBayer to Buy Gene-Therapy Firm AskBio for Up to $4 Billion
DJ
03:34aBAYER : acquires Asklepios BioPharmaceutical to broaden innovation base in cell ..
PU
10/23BAYER : FDA approves FoundationOne®CDx as companion diagnostic for Vitrakvi&trad..
PU
10/23BAYER : drug shown to slow diabetic kidney disease
RE
10/22BAYER : Request for Roundup Appeal Rejected by California Court
DJ
10/21BAYER : Monsanto loses final appeal over French farmer's weedkiller accident
RE
10/21BAYER AG : JP Morgan gives a Neutral rating
MD
10/21BAYER AG : Morgan Stanley reiterates its Buy rating
MD
10/19Bayer's Orbia plans Latam expansion after Bunge deal in Brazil
RE
10/19BAYER AG : UBS keeps its Buy rating
MD
10/16BAYER : Leaps by Bayer leads USD 17 million Series B financing in biotech compan..
AQ
More most relevant news
All news about BAYER AG
10:33aWALL STREET STOCK EXCHANGE : US companies under China sanctions, Many acquisitio..
09:44aBAYER : Finerenone significantly reduced renal and cardiovascular outcomes in pa..
AQ
09:16aNEWS HIGHLIGHTS : Top Company News of the Day
DJ
08:35aBAYER : Rivaroxaban application submitted to U.S. FDA for new indication in pati..
PU
07:51aBayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 bill..
RE
07:45aBAYER AG : UBS keeps its Buy rating
MD
07:32aBAYER AG : Buy rating from Goldman Sachs
MD
03:45aBayer to Buy Gene-Therapy Firm AskBio for Up to $4 Billion
DJ
03:34aBAYER : acquires Asklepios BioPharmaceutical to broaden innovation base in cell ..
PU
03:30aBayer to pay $2 billion upfront and up to an additional $2 billion in milesto..
RE
More news
News in other languages on BAYER AG
10:21aDPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 26.10.2020 - 15.15 Uhr
10:14aLa FDA approuve un test sur les tumeurs d'une filiale de Roche
10:03aBörse Stuttgart-News: Euwax Trends
07:45aBAYER AG : UBS persiste à l'achat
07:45aUBS belässt Bayer auf 'Buy' - Ziel 85 Euro
07:32aBAYER AG : Goldman Sachs optimiste sur le dossier
07:32aGoldman belässt Bayer auf 'Buy' - Ziel 75 Euro
07:05aBAYER : achète Asklepios Bio et se renforce dans la thérapie génique
07:00aAktien Frankfurt: SAP-Kurssturz zieht Dax runter
06:20aAktien Europa: SAP sorgt beim EuroStoxx für neuen Rücksetzer
Analyst Recommendations on BAYER AG
07:45aBAYER AG : UBS keeps its Buy rating
MD
07:32aBAYER AG : Buy rating from Goldman Sachs
MD
10/21BAYER AG : JP Morgan gives a Neutral rating
MD
10/21BAYER AG : Morgan Stanley reiterates its Buy rating
MD
10/19BAYER AG : UBS keeps its Buy rating
MD
More recommendations
Press releases
09:44aBAYER : Finerenone significantly reduced renal and cardiovascular outcomes in pa..
AQ
08:35aBAYER : Rivaroxaban application submitted to U.S. FDA for new indication in pati..
PU
03:34aBAYER : acquires Asklepios BioPharmaceutical to broaden innovation base in cell ..
PU
10/23BAYER : FDA approves FoundationOne®CDx as companion diagnostic for Vitrakvi&trad..
PU
10/16BAYER : Leaps by Bayer leads USD 17 million Series B financing in biotech compan..
AQ
More press releases
Upcoming event on BAYER AG